A carregar...
A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
BACKGROUND: MVA85A and AERAS-402 are two clinically advanced viral vectored TB vaccine candidates expressing Mycobacterium tuberculosis antigens designed to boost BCG-induced immunity. Clinical trials with candidate malaria vaccines have demonstrated that adenoviral vector based priming immunisation...
Na minha lista:
Publicado no: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4631471/ https://ncbi.nlm.nih.gov/pubmed/26529238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141687 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|